CAS: 19968-85-5; 1-(Aminomethyl)Cyclohexan-1-Ol Hydrochloride

该化合物是一种化学化合物,其特点是环氧乙醇混合物,与氨基甲基混合物替代,形成盐盐,该化合物一般是白色晶状固体,可溶于水中,因为存在盐酸混合物会增加其极性,氨基氨基甲酸酯组的存在表明,它可以参与各种化学反应,包括核生殖替代和与生物系统的潜在相互作用,从而引起对药用化学的兴趣.其结构允许氢结合,从而影响其物理特性和再活性.Cyclohexanol衍生物经常被研究用于制药和有机合成的中间体.在处理和储存时,应参考安全数据,如任何化学物质一样,以确保根据潜在毒性或再活度采取适当的预防措施.

结构式图片

相似化合物

4000-72-0 113912-41-7 885954-83-6

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-5173282-A
    优先权日:1991-10-04
    标题:Synthesis of crystalline mordenite-type material
    发明人:HELLRING STUART D; STRIEBEL RANDY F
    权利人:MOBIL OIL CORP
    摘要:This invention relates to a new form of crystalline mordenite-type material, to a new and useful method for synthesizing said crystalline material and to use of said crystalline material prepared in accordance herewith as a catalyst for organic compound, e.g. hydrocarbon compound, conversion.

    专利号:US-8129411-B2
    优先权日:2005-12-30
    标题:Organic compounds
    发明人:EHARA TAKERU; GROSCHE PHILIPP; IRIE OSAMU; IWAKI YUKI; KANAZAWA TAKANORI; KAWAKAMI SHIMPEI; KONISHI KAZUHIDE; MOGI MUNETO; SUZUKI MASAKI; YOKOKAWA FUMIAKI
    权利人:EHARA TAKERU; GROSCHE PHILIPP; IRIE OSAMU; IWAKI YUKI; KANAZAWA TAKANORI; KAWAKAMI SHIMPEI; KONISHI KAZUHIDE; MOGI MUNETO; SUZUKI MASAKI; YOKOKAWA FUMIAKI; NOVARTIS AG
    摘要:The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. n The compounds have the formula I′ n nwherein R1, R2, T, R3 and R4 are as defined in the specification.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: A Jarrahian, Et Al. Structure-Activity Relationships Among N-Arachidonylethanolamine (Anandamide) Head Group Analogues For The Anandamide Transporter. J Neurochem. 2000 Jun;74(6):2597-606.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知